Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration

scientific article published on 22 January 2011

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JAC/DKQ545
P698PubMed publication ID21393208

P2093author name stringValentin Fuhrmann
Walter Jäger
Brigitte Meyer
Florian Thalhammer
Judith M Leitner
Michaela Böhmdorfer
Clara Zuba
Katrin Saria
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpharmacokineticsQ323936
P304page(s)880-884
P577publication date2011-01-22
P1433published inJournal of Antimicrobial ChemotherapyQ6294770
P1476titleMultiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration
P478volume66

Reverse relations

cites work (P2860)
Q41921220Anidulafungin dosing during CRRT: do not underestimate adsorption!
Q38382954Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration
Q53217028Current role of echinocandins in the management of invasive aspergillosis.
Q54957028Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.
Q64926124Ex vivo Rezafungin Adsorption and Clearance During Continuous Renal Replacement Therapy.
Q48192025Filter Adsorption of Anidulafungin to a Polysulfone-Based Hemofilter During CVVHD In Vitro
Q26999448How to manage aspergillosis in non-neutropenic intensive care unit patients
Q38462784Impact of special patient populations on the pharmacokinetics of echinocandins.
Q38375996Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients
Q42326553Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
Q38681635Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Q37036404Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy.
Q57746174Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins
Q38153458The Eagle-like effect of echinocandins: what's in a name?
Q37985070The use of antifungal therapy in neonatal intensive care.
Q27012864Treatment with echinocandins during continuous renal replacement therapy
Q87469389[Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment]

Search more.